Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use

Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use

Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in the effectiveness to some other actively developing...

Full description

Saved in:
Bibliographic Details
Main Authors: D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-05-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
diabetes mellitus
dipeptidyl peptidase 4
glucagonlike peptide-1
glucose-dependent insulinotropic peptide
sitagliptin
covid-19
Online Access:https://www.pharmpharm.ru/jour/article/view/1257
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmpharm.ru/jour/article/view/1257

Similar Items